Asceneuron
Develops effective therapeutics for orphan tauopathies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD545—818m (Dealroom.co estimates Jul 2024.)
Company register number CH-550.1.113.419-7
Lausanne Canton of Vaud (HQ)
Authorizing premium user...